No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DOOO240719C70000
- 1.35
- +0.75+125.00%
15min DelayClose Jul 16 15:59 ET
1.35High1.05Low
1.05Open0.60Pre Close4 Volume35 Open Interest70.00Strike Price473.00Turnover29.30%IV0.65%PremiumJul 19, 2024Expiry Date0.89Intrinsic Value100Multiplier2DDays to Expiry0.46Extrinsic Value100Contract SizeAmericanOptions Type0.6921Delta0.1854Gamma54.53Leverage Ratio-0.1246Theta0.0040Rho37.74Eff Leverage0.0228Vega
Intraday
- 5D
- Daily
News
BRP Is Maintained at Buy by Citigroup
BRP Is Maintained at Buy by
BRP Inc. Price Target Raised to C$110.00/Share From C$100.00 by Citigroup
BRP Inc. Price Target Raised to C$110.00/Share From C$100.00 by
Citi Maintains BRP(DOOO.US) With Buy Rating, Raises Target Price to $80
Citi analyst James Hardiman maintains $BRP(DOOO.US)$ with a buy rating, and adjusts the target price from $73 to $80.According to TipRanks data, the analyst has a success rate of 49.8% and a total
Express News | BRP Inc : Citigroup Raises Target Price to $80 From $73
SEA-DOO ISSUES TOP FIVE PERSONAL WATERCRAFT SAFETY TIPS
BRP To Go Ex-Dividend On June 28th, 2024 With 0.15663 USD Dividend Per Share
June 26th (Eastern Time) - $BRP(DOOO.US)$ is trading ex-dividend on June 28th, 2024.Shareholders of record on June 28th, 2024 will receive 0.15663 USD dividend per share on July 12th, 2024. The ex-div
Comments
BRP's term loan facility amendment and extension is a strategic move to maintain a robust balance sheet and enhance operational and investment flexibility for long-term growth, says CFO Sébastien Martel.
Press Release: BRP ANNOUNCES AMENDMENT AND EXTENSION OF ITS TERM FACILITY 1
Investors seem uncertain about BRP Group's ability to meet growth expectations despite superior revenue outlook, reflecting in its industry-average P/S ratio. The uncertainty in revenue forecasts indicates possible future volatility.
Gapping up
In reaction to earnings/guidance:
• $Evolution Petroleum(EPM.US$ +9%, $Radiant Logistics(RLGT.US$ +5.3%, $BRP(DOOO.US$ +1.4%, $Goosehead Insurance(GSHD.US$ +1%, $Ashland(ASH.US$ +0.9%, $RTX Corp(RTX.US$ +0.7%
Other news:
• $Delwinds Insurance(DWIN.US$ +18.5% (announces forward purchase agreement and amended backstop agreements)
• $NGM Biopharmaceuticals(NGM.US$ +6.1% (provides preliminary findings for Pha...
In reaction to earnings/guidance:
• $Evolution Petroleum(EPM.US$ +9%, $Radiant Logistics(RLGT.US$ +5.3%, $BRP(DOOO.US$ +1.4%, $Goosehead Insurance(GSHD.US$ +1%, $Ashland(ASH.US$ +0.9%, $RTX Corp(RTX.US$ +0.7%
Other news:
• $Delwinds Insurance(DWIN.US$ +18.5% (announces forward purchase agreement and amended backstop agreements)
• $NGM Biopharmaceuticals(NGM.US$ +6.1% (provides preliminary findings for Pha...
12
3
Gainers:
• $Okta(OKTA.US$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
• $Okta(OKTA.US$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
25
2
I would do your own research and make sure you develop an investment strategy that suits your needs. For me I have bought into a lot of dividend growth and tech.
My tech holdings are: $Microsoft(MSFT.US$ $EPAM Systems(EPAM.US$ $Endava(DAVA.US$ $MercadoLibre(MELI.US$ $Sea(SE.US$ $Alphabet-C(GOOG.US$
But the catch is I didn’t buy these all recently, like Msft I bought at $190. Dava and epam were more recent, same with meli and se on the recent tech crash. I have decent cashflow tho to deploy money. I can deploy about 4K a month into the market after expenses, not including my dividends from stocks.
My dividend stocks are: $Lockheed Martin(LMT.US$ $Northrop Grumman(NOC.US$ $Agree Realty Corp(ADC.US$ $VICI Properties(VICI.US$ $Stag Industrial Inc(STAG.US$ $BRP(DOOO.US$
Some were bought last year some I averaged into this year. Make sure you do your own due diligence tho bcuz a crash could very well be on the horizon and nothing will be safe if the overall markets plummet. I don’t try to time the market, so I keep some cash on hand and consistently buy. That’s just me tho, some ppl can’t handle looking at heavy losses and have weak hands (used to be me years ago when I first started at 18-19, now 28)
My tech holdings are: $Microsoft(MSFT.US$ $EPAM Systems(EPAM.US$ $Endava(DAVA.US$ $MercadoLibre(MELI.US$ $Sea(SE.US$ $Alphabet-C(GOOG.US$
But the catch is I didn’t buy these all recently, like Msft I bought at $190. Dava and epam were more recent, same with meli and se on the recent tech crash. I have decent cashflow tho to deploy money. I can deploy about 4K a month into the market after expenses, not including my dividends from stocks.
My dividend stocks are: $Lockheed Martin(LMT.US$ $Northrop Grumman(NOC.US$ $Agree Realty Corp(ADC.US$ $VICI Properties(VICI.US$ $Stag Industrial Inc(STAG.US$ $BRP(DOOO.US$
Some were bought last year some I averaged into this year. Make sure you do your own due diligence tho bcuz a crash could very well be on the horizon and nothing will be safe if the overall markets plummet. I don’t try to time the market, so I keep some cash on hand and consistently buy. That’s just me tho, some ppl can’t handle looking at heavy losses and have weak hands (used to be me years ago when I first started at 18-19, now 28)
57
2
Read more